X0306 4 2020-02-19 0 0001016169 ANTARES PHARMA, INC. ATRS 0001235635 GRAHAM PETER J C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300 EWING NJ 08628 0 1 0 0 EVP General Counsel, Secretary Common Stock 2020-02-19 4 A 0 63234 0.00 A 449495 D Common Stock 2020-02-19 4 F 0 29947 3.53 D 419548 D On August 25, 2017, Mr. Graham was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three year performance period ended December 31, 2019. The number of shares acquired represent the total number of shares earned upon achievement of certain performance goals, the achievement of which was certified on February 19, 2020. The shares disposed represents the number of shares withheld to settle tax liability in connection with the vesting of the performance stock unit award. /s/ Keith Muckenhirn as attorney-in-fact for Peter J. Graham 2020-02-21